Comparison between Influx Healthtech IPO and Saffron Speciality Papers IPO.
Influx Healthtech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Saffron Speciality Papers IPO is a SME Bookbuilding proposed to list at BSE SME.
| Influx Healthtech IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Rarever Financial Advisors Pvt.Ltd. | BOI Merchant Bankers Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | NSDL Database Management Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Influx Healthtech IPO is up to ₹55.63 Cr whereas the issue size of the Saffron Speciality Papers IPO is up to ₹0.00 Cr. The final issue price of Influx Healthtech IPO is ₹96.00 per share and of Saffron Speciality Papers IPO is .
| Influx Healthtech IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | |
| Issue Price (Upper) | ₹96.00 per share | |
| Issue Price (Final) | ₹96.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 46,94,400 shares | 55,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹45.07 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 11,00,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹10.56 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,94,800 shares | 55,60,000 shares |
| Issue Size Total (Amount) | up to ₹55.63 Cr | up to ₹0.00 Cr |
Influx Healthtech IPO opens on Jun 18, 2025, while Saffron Speciality Papers IPO opens on . The closing date of Influx Healthtech IPO and Saffron Speciality Papers IPO is Jun 20, 2025, and , respectively.
| Influx Healthtech IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2025 | |
| Issue Open | Jun 18, 2025 | |
| Issue Close | Jun 20, 2025 | |
| Basis Of Allotment (Tentative) | Jun 23, 2025 | |
| Initiation of Refunds (Tentative) | Jun 24, 2025 | |
| Credit of Share (Tentative) | Jun 24, 2025 | |
| Listing date (Tentative) | Jun 25, 2025 | |
| Anchor Lockin End date 1 | Jul 23, 2025 | |
| Anchor Lockin End date 2 | Sep 21, 2025 |
Influx Healthtech IPO P/E ratio is 13.04, as compared to Saffron Speciality Papers IPO P/E ratio of .
| Influx Healthtech IPO | Saffron Speciality Papers IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Influx Healthtech Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.85 | 89.4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹222.24 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.98% | 37.48% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 49.17% | 24.06% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | 3.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.98% | 37.48% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Influx Healthtech IPO Retail Individual Investors (RII) are offered 20,29,200 shares while in Saffron Speciality Papers IPO retail investors are offered 20,29,200 shares. Qualified Institutional Buyers (QIB) are offered 11,59,200 shares in Influx Healthtech IPO and 0 shares in Saffron Speciality Papers IPO.
| Influx Healthtech IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,36,400 shares | 0 shares |
| Market Maker Reservation | 3,06,000 shares | 0 shares |
| QIB | 11,59,200 shares | 0 shares |
| NII | 8,70,000 shares | 0 shares |
| RII | 20,29,200 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 57,94,800 shares | 0 shares |
Influx Healthtech IPO subscribed 201.35x in total, whereas Saffron Speciality Papers IPO subscribed .
| Influx Healthtech IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| QIB (times) | 137.87x | |
| NII (times) | 481.10x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 117.68x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 201.35x |
